Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017

世界のドラッグデリバリー(薬物送達)技術市場

◆タイトル:Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017
◆商品コード: BT 1539
◆調査・発行会社:MarketsandMarkets
◆発行日:2013年4月
◆ページ数:316
◆レポート形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single userUSD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User(~5名まで)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate licence(社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"世界のドラッグデリバリー(薬物送達)技術市場"について調査・分析し、イントロダクション、エグゼクティブサマリー、市場概観、市場の成長要因、阻害要因、市場の機会と課題、バリューチェーン分析、市場環境分析、市場の動態、技術別分析、地域別分析、市場規模及び予測、競争状況、市場シェア分析、新製品発売、主要企業(ベンダー)分析等の情報をお届けいたします。

The drug delivery technology market is segmented on the basis of route of administration into nine categories – oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery; the market is forecast till 2017. Over the years, drug delivery technologies have grown phenomenally from plain drug reformulation and release technologies to innovative platforms that hold a huge potential for the effective delivery of biologicals and novel drugs.

The global drug delivery market was worth $142.5 billion in the year 2012. Patent expiries of certain blockbuster drugs, growing demand for self administration and home healthcare devices, rising incidence of chronic diseases such as cardiovascular diseases, diabetes and cancer, growing focus on pediatric and geriatric patients, and advancing technology are accelerating the growth of this market. However, drug failures and recalls, and technical barriers will hamper the growth of this market, to a certain extent.

Strategic collaborations, self administration and home care drug delivery devices, and expanding applications of drug delivery into niche therapeutic areas represent vast opportunities for key players in this market. The growing number of elderly persons is a large consumer of home care drug delivery devices. The global ageing population (above 60 years) is set to increase from 784 million in 2011 to 2 billion by 2050 and 2.8 billion by 2100. (Source: UN Population Division). An increase in the number of geriatric patients and rise in demand for convenient drug delivery options pose major opportunities for the development of innovative and easy-to-use drug delivery systems.

Striking right partnership deal and enhancing the bioavailability of drugs are some of the burning issues in this market. In spite of a large number of strategic collaborations taking place every year, pharmaceutical and biotechnology companies are facing problems in finding a right drug delivery partner. Considering this need, a number of national and international conferences are organized by various associations and organizations to facilitate drug delivery partnerships.

The geographies covered in this study are North America, Europe, Asia and Rest of the world (RoW). North America is the largest market for drug delivery, followed by Europe and Asia. North America and Europe are expected to grow at a slower pace, primarily due to a certain amount of saturation in the market. The Asian market is poised to register maximum growth over the next five years, owing to the expansion of Asian economy, increase in disposable income, development of healthcare infrastructure, increasing penetration of health insurance, and rising prevalence of chronic diseases.

Scope of the Report

This research report categorizes the global drug delivery market into oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the drug delivery market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.

Global drug delivery market, by route of administration

Oral
Controlled Release
Orodispersible Tablets (ODT) and Taste Masking
Others
Pulmonary
Dry Powder Inhalers
Metered Dose Inhalers
Nebulizers
Transdermal
Passive
Reservoir System
Matrix System
Active
Iontophoresis
Microporation
Others
Injectable
Conventional Injection Devices
Fillable Syringes
Prefilled Syringes
Self-injection Devices
Needle-free Injectors
Auto-injectors or Safety Syringe Devices
Pen Injectors
Others
Ocular
Eye Drops
Ointment and Gel
Others
Nasal
Nasal Drops
Nasal Sprays
Nasal Inhalers
Others
Topical
Liquid Formulations
Semi-solid Formulations
Solid Formulations
Implantable
Drug Eluting Stents
Implantable Infusion Pumps
Intravitreal Implants
Brachytherapy Seeds
Contraceptive Implants
Transmucosal
Oral (Buccal and Sublingual)
Others (Rectal and Vaginal)
Geographic analysis

North America
Europe
Asia
Rest of the World (RoW)

【レポートの目次】

Table Of Contents

1 Introduction (Page No. – 23)
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
1.5.5 Assumptions

2 Executive Summary (Page No. – 29)

3 Market Overview (Page No. – 34)
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Patent Cliff And Increased Competition To Increase Adoption Rate
3.3.1.2 Improving Patient Compliance And Acceptability, An Impetus To The Market
3.3.1.3 Increasing Focus On Pediatric And Geriatric Patients To Boost The Growth
3.3.1.4 Increasing Incidence Of Chronic Diseases To Enhance Demand
3.3.2 Restraints
3.3.2.1 Drug Failures And Recalls Mar Market Growth
3.3.2.2 Technical Barriers Restrict Growth
3.3.3 Opportunities
3.3.3.1 Collaborations Between Pharmaceutical Companies And Drug Delivery Firms
3.3.3.2 Self-Administration And Home Care Drug Delivery Technology
3.3.3.3 Expanding Therapeutic Applications Of Drug Delivery Technology
3.3.4 Targeted Drug Delivery
3.3.4.1 Passive Systems Contribute 60% To The Targeted Market
3.3.4.2 Active Targeted Drug Delivery Has Major Applications In Cancer Therapy
3.3.4.3 Companies Focus On Novel Targeted Drug Delivery
3.3.5 Burning Issues
3.3.5.1 Striking Right Partnerships
3.3.5.2 Improving The Bioavailability Of Drugs
3.4 Regulatory Environment
3.4.1 Stringent Regulations For Pharmaceutical Drugs Across The Globe
3.4.1.1 The Approval Process Is Complex, Time-Consuming, And Expensive
3.4.2 Effect Of The U.S. Healthcare Reforms On The Drug Delivery Industry
3.4.3 Regulations Related To The Approval Of Controlled Release Drugs
3.5 Porter’s Five Forces Analysis
3.6 Value Chain Analysis
3.7 Market Share Analysis
3.7.1 Pulmonary Drug Delivery
3.7.2 Transdermal Drug Delivery
3.7.3 Injectable Drug Delivery
3.7.3.1 Conventional Injection Devices
3.7.3.2 Self-Injection Devices
3.7.4 Implantable Drug Delivery
3.7.5 Other Drug Delivery Segments

4 Global Market, By Technology (Page No. – 61)
4.1 Introduction
4.1.1 Drug Delivery Technology Market Witnessing Technological Advancements
4.2 Opportunity Matrix
4.3 Oral Drug Delivery Technology Market
4.3.1 Big Pharma Companies Establishing In-House Capabilities
4.3.2 Controlled Release
4.3.3 Orodispersible Tablets (ODT) And Taste Masking
4.3.4 Others
4.4 Pulmonary Drug Delivery Technology Market
4.4.1 Therapeutic Applications Of Pulmonary Delivery
4.4.1.1 Application Of Pulmonary Delivery For Non-Respiratory Therapies Is A Growing Opportunity
4.4.2 Metered Dose Inhalers (MDI)
4.4.3 Dry Powder Inhalers (DPI)
4.4.4 Nebulizers
4.5 Transdermal Drug Delivery Technology Market
4.5.1 Passive Transdermal Drug Delivery
4.5.1.1 Matrix System
4.5.1.2 Reservoir System
4.5.2 Active Transdermal Drug Delivery
4.5.2.1 Microporation
4.5.2.2 Iontophoresis
4.5.2.3 Others
4.6 Injectable Drug Delivery
4.6.1 Injectable Drug Delivery Market Witnessing Developments Related To Product Improvement
4.6.2 Conventional Injectable Drug Delivery Technology
4.6.2.1 Low Manufacturing Cost And Affordable Prices: Key Driver For Conventional Injection Devices
4.6.2.2 Fillable
4.6.2.3 Prefilled
4.6.3 Self-Injection Devices
4.6.3.1 Self-Injection Devices Reduce Overall Treatment Cost
4.6.3.2 Pen Injectors
4.6.3.3 Needle-Free Injectors
4.6.3.4 Auto Injectors
4.6.4 Others
4.7 Ocular Drug Delivery Technology Market
4.7.1 Eye Drops
4.7.2 Ointments And Gels
4.7.3 Others
4.8 Nasal Drug Delivery Technology Market
4.8.1 Nasal Drug Delivery Preferred For Locally Acting Drugs And Delivery Of Vaccines
4.8.2 Nasal Sprays
4.8.3 Nasal Inhalers
4.8.4 Nasal Drops
4.8.5 Others
4.9 Topical Drug Delivery Technology Market
4.9.1 Topical Delivery Majorly Adopted For Dermatology Drugs
4.9.2 Semi-Solid Formulations
4.9.3 Liquid Formulations
4.9.4 Solid Formulations
4.10 Implantable Drug Delivery Technology Market
4.10.1 Drug- Eluting Stents
4.10.2 Implantable Infusion Pumps
4.10.2.1 Implantable Infusion Pumps Largely Used For Therapies Of Chronic Ailments
4.10.3 Contraceptive Implants
4.10.4 Intravitreal Implants
4.10.5 Brachytherapy Seeds
4.11 Transmucosal Drug Delivery Technology Market
4.11.1 Oral (Buccal And Sublingual)
4.11.2 Others (Rectal, Vaginal)

5 Geographic Analysis (Page No. – 143)
5.1 Introduction
5.2 North America
5.2.1 Healthcare Reforms In The U.S. Will Impact The Drug Delivery Technology Market
5.3 Europe
5.4 Asia
5.4.1 Booming Pharmaceutical Industry Set To Accelerate The Growth
5.5 Rest Of The World (ROW)

6 Competitive Landscape (Page No. – 190)
6.1 Introduction
6.2 Mergers & Acquisitions
6.3 Agreements, Collaborations, Joint Ventures & Partnerships
6.4 New Product Launch
6.5 Other Developments

7 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 209)
7.1 3m Company
7.2 Alkermes, Inc.
7.3 Aptalis Pharma, Inc.
7.4 Baxter International, Inc.
7.5 Becton, Dickinson And Company
7.6 Catalent Pharma Solutions
7.7 Cima Labs
7.8 Dali Medical Devices
7.9 Endo Health Solutions, Inc.
7.10 Foamix
7.11 Johnson & Johnson, Inc.
7.12 Nektar Therapeutics, Inc.
7.13 Optinose AS
7.14 Psivida Corporation
7.15 Skyepharma PLC
7.16 Tapemark
7.17 The Dow Chemical Company
7.18 Valeant Pharmaceuticals
7.19 Ypsomed Holding AG
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.

List Of Tables (118 Tables)

Table 1 Global Market, By Route Of Administration, 2010 - 2017 ($Billion)
Table 2 Key Drug Delivery Technology Providers & Marketer Companies
Table 3 Global Oral Drug Delivery Market, By Technology,2010 - 2017 ($Billion)
Table 4 Oral Market, By Geography,2010 - 2017 ($Billion)
Table 5 Controlled Release Drug Delivery Market, By Geography, 2010 - 2017 ($Billion)
Table 6 ODT & Taste-Masking Market, By Geography,2010 - 2017 ($Billion)
Table 7 Other Oral Drug Delivery Technology Market,By Geography, 2010 - 2017 ($Billion)
Table 8 Global Pulmonary Drug Delivery Market, By Device Type,2010 - 2017 ($Billion)
Table 9 Pulmonary Drug Delivery Market, By Geography,2010 - 2017 ($Billion)
Table 10 Comparative Overview Of Pulmonary Drug Delivery Devices
Table 11 Metered Dose Inhalation Market, By Geography,2010 - 2017 ($Billion)
Table 12 Dry Powder Inhalation Market, By Geography,2010 - 2017 ($Billion)
Table 13 Nebulizers Market, By Geography, 2010 - 2017 ($Billion)
Table 14 Global Transdermal Drug Delivery Market, By Mode Of Delivery, 2010 - 2017 ($Billion)
Table 15 Transdermal Drug Delivery Market, By Geography,2010 - 2017 ($Billion)
Table 16 Passive Transdermal Drug Delivery Market, By Product Type, 2010 - 2017 ($Billion)
Table 17 Passive Transdermal Drug Delivery Market, By Geography, 2010 - 2017 ($Billion)
Table 18 Active Transdermal Drug Delivery Market, By Technology, 2010 - 2017 ($Million)
Table 19 Active Transdermal Drug Delivery Market, By Geography, 2010 - 2017 ($Million)
Table 20 Global Injectable Drug Delivery Market, By Product Type, 2010 - 2017 ($Billion)
Table 21 Injectable Drug Delivery Market, By Geography,2010 - 2017 ($Billion)
Table 22 Conventional Injection Devices Market, By Product,2010 - 2017 ($Billion)
Table 23 Conventional Injection Devices Market, By Geography,2010 - 2017 ($Billion)
Table 24 Global Self-Injection Devices Market, By Product,2010 - 2017 ($Million)
Table 25 Self-Injection Devices Market, By Geography,2010 - 2017 ($Million)
Table 26 Other Injectors Market, By Geography, 2010 - 2017 ($Million)
Table 27 Global Ocular Drug Delivery Market, By Formulation,2010 - 2017 ($Billion)
Table 28 Ocular Drug Delivery Market, By Geography,2010 - 2017 ($Billion)
Table 29 Eye Drop Drug Delivery Market, By Geography,2010 - 2017 ($Billion)
Table 30 Ointment & Gel Delivery Market, By Geography,2010 - 2017 ($Million)
Table 31 Other Ocular Drug Delivery Market, By Geography,2010 - 2017 ($Million)
Table 32 Global Nasal Drug Delivery Market, By Formulation,2010 - 2017 ($Billion)
Table 33 Nasal Drug Delivery Market, By Geography,2010 - 2017 ($Billion)
Table 34 Nasal Spray Market, By Geography, 2010 - 2017 ($Billion)
Table 35 Nasal Inhaler Market, By Geography, 2010 - 2017 ($Million)
Table 36 Nasal Drops Market, By Geography, 2010 - 2017 ($Million)
Table 37 Other Nasal Delivery Formulations Market, By Geography, 2010 - 2017 ($Million)
Table 38 Global Topical Drug Delivery Market, By Formulation,2010 - 2017 ($Billion)
Table 39 Topical Drug Delivery Market, By Geography,2010 - 2017 ($Billion)
Table 40 Semi-Solid Topical Formulation Market, By Geography,2010 - 2017 ($Billion)
Table 41 Liquid Topical Formulation Market, By Geography,2010 - 2017 ($Million)
Table 42 Solid Topical Formulation Market, By Geography,2010 - 2017 ($Million)
Table 43 Global Implantable Drug Delivery Market, By Device,2010 - 2017 ($Billion)
Table 44 Implantable Drug Delivery Market, By Geography,2010 - 2017 ($Billion)
Table 45 Drug-Eluting Stents Market, By Geography,2010 - 2017 ($Billion)
Table 46 Implantable Infusion Pumps Market, By Geography,2010 - 2017 ($Billion)
Table 47 Contraceptive Implants Market, By Geography,2010 - 2017 ($Million)
Table 48 Intravitreal Implants Market, By Geography,2010 - 2017 ($Million)
Table 49 Brachytherapy Seeds Market, By Geography,2010 - 2017 ($Million)
Table 50 Global Transmucosal Drug Delivery Market, By Mucosa Type, 2010 - 2017 ($Billion)
Table 51 Global Transmucosal Drug Delivery Market, By Geography, 2010 - 2017 ($Billion)
Table 52 Oral Transmucosal Drug Delivery Market, By Geography,2010 - 2017 ($Billion)
Table 53 Other Transmucosal Drug Delivery Technology Market,By Geography, 2010 - 2017 ($Million)
Table 54 Drug Delivery Market, By Geography, 2010 - 2017 ($Billion)
Table 55 North America: Drug Delivery Market, By Route Of Administration, 2010 - 2017 ($Billion)
Table 56 North America: Oral Market, By Technology, 2010 - 2017 ($Billion)
Table 57 North America: Pulmonary Market, By Device Type, 2010 - 2017 ($Billion)
Table 58 North America: Transdermal Market, By Mode Of Delivery, 2010 - 2017 ($Billion)
Table 59 North America: Injectable Market,By Technology, 2010 - 2017 ($Billion)
Table 60 North America: Ocular Market,By Formulation, 2010 - 2017 ($Billion)
Table 61 North America: Nasal Market, By Formulation, 2010 - 2017 ($Billion)
Table 62 North America: Topical Market,By Formulation, 2010 - 2017 ($Million)
Table 63 North America: Implantable Market, By Device Type, 2010 - 2017 ($Million)
Table 64 North America: Transmucosal Market,By Mucosa Type, 2010 - 2017 ($Million)
Table 65 Europe: Drug Delivery Technologies Market, By Route Of Administration, 2010 - 2017 ($Billion)
Table 66 Europe: Oral Market, By Technology,2010 - 2017 ($Billion)
Table 67 Europe: Pulmonary Market, By Device Type,2010 - 2017 ($Billion)
Table 68 Europe: Transdermal Market, By Mode Of Delivery, 2010 - 2017 ($Billion)
Table 69 Europe: Injectable Market, By Technology, 2010 - 2017 ($Million)
Table 70 Europe: Ocular Market, By Formulation,2010 - 2017 ($Million)
Table 71 Europe: Nasal Market, By Formulation,2010 - 2017 ($Million)
Table 72 Europe: Topical Market, By Formulation,2010 - 2017 ($Million)
Table 73 Europe: Implantable Market, By Device Type, 2010 - 2017 ($Million)
Table 74 Europe: Transmucosal Market, By Mucosa Type, 2010 - 2017 ($Million)
Table 75 Asia: Drug Delivery Technologies Market, By Route Of Administration, 2010 - 2017 ($Billion)
Table 76 Asia: Oral Market, By Technology,2010 - 2017 ($Billion)
Table 77 Asia: Pulmonary Market, By Device Type,2010 - 2017 ($Billion)
Table 78 Asia: Transdermal Market, By Mode Of Delivery, 2010 - 2017 ($Billion)
Table 79 Asia: Injectable Market, By Technology,2010 - 2017 ($Million)
Table 80 Asia: Ocular Market, By Formulation,2010 - 2017 ($Million)
Table 81 Asia: Nasal Market, By Formulation,2010 - 2017 ($Million)
Table 82 Asia: Topical Market, By Formulation,2010 - 2017 ($Million)
Table 83 Asia: Implantable Market, By Device Type,2010 - 2017 ($Million)
Table 84 Asia: Transmucosal Market, By Mucosa Type, 2010 - 2017 ($Million)
Table 85 ROW: Drug Delivery Technologies Market, By Route Of Administration, 2010 - 2017 ($Billion)
Table 86 ROW: Oral Market, By Technology,2010 - 2017 ($Billion)
Table 87 ROW: Pulmonary Market, By Device Type,2010 - 2017 ($Billion)
Table 88 ROW: Transdermal Market, By Technology,2010 - 2017 ($Million)
Table 89 ROW: Injectable Market, By Technology,2010 - 2017 ($Million)
Table 90 ROW: Ocular Market, By Formulation,2010 - 2017 ($Million)
Table 91 ROW: Nasal Market, By Formulation,2010 - 2017 ($Million)
Table 92 ROW: Topical Market, By Formulation,2010 - 2017 ($Million)
Table 93 ROW: Implantable Market, By Device Type,2010 - 2017 ($Million)
Table 94 ROW: Transmucosal Market, By Mucosa Type, 2010 - 2017 ($Million)
Table 95 Mergers & Acquisitions, 2011 –2013
Table 96 Agreements, Collaborations, Joint Ventures & Partnerships, 2011 –2013
Table 97 New Product Launch, 2010 - 2012
Table 98 Other Developments, 2010 - 2013
Table 99 3M Company: Total Revenue, By Segment, 2009 - 2011 ($Million)
Table 100 3M Company: Total Revenue, By Geography,2009 - 2011 ($Million)
Table 101 Alkermes: Total Revenue, By Geography, 2009 - 2011 ($Million)
Table 102 Baxter International: Total Revenue, By Segment,2010 - 2012 ($Million)
Table 103 Baxter International: Medical Products Total Revenue,2010 - 2012($Million)
Table 104 Baxter International: Total Revenue, By Geography,2010 - 2012 ($Million)
Table 105 Becton, Dickinson: Total Revenue, By Segment,2010 - 2012 ($Million)
Table 106 Becton, Dickinson: Medical Division Total Revenue,By Segment, 2010 - 2012 ($Million)
Table 107 Becton, Dickinson: Total Revenue, By Geography,2010 - 2012($Million)
Table 108 Catalent Pharma Solutions: Total Revenue, By Segment,2009 - 2011 ($Million)
Table 109 Teva Pharmaceutical Industries Limited: Total Revenue,By Segment, 2010 - 2012 ($Million)
Table 110 Teva Pharmaceutical Industries Limited: Total Revenue,By Geography, 2010 - 2012 ($Million)
Table 111 Endo Health Solutions, Inc.: Total Revenue, By Segment,2010 - 2012 ($Million)
Table 112 Johnson & Johnson, Inc.: Total Revenue, By Segment,2010 - 2012 ($Million)
Table 113 Johnson & Johnson, Inc.: Total Revenue, By Geography,2010 - 2012 ($Million)
Table 114 The Dow Chemical Company: Total Revenue, By Segment,2010 - 2012 ($Million)
Table 115 Valeant Pharmaceuticals: Total Revenue, By Geography,2010 - 2012 ($Million)
Table 116 Ypsomed: Total Revenue, By Segment, 2009 - 2011 ($Million)
Table 117 Ypsomed: Total Revenue, By Geography, 2009 ($Million)
Table 118 Ypsomed: Total Revenue, By Geography, 2010 - 2011 ($Million)


List Of Figures (29 Figures)

Figure 1 Global Market, By Route Of Administration (2012)
Figure 2 Drug Delivery Technology Market, By Geography, 2010 - 2017 ($Billion)
Figure 3 Global Market Segmentation
Figure 4 Market Dynamics
Figure 5 Porter’s Five Forces Analysis For Drug Delivery Market
Figure 6 Value Chain Analysis
Figure 7 Global Pulmonary: Market Share Analysis,By Key Player, 2012
Figure 8 Global Transdermal: Market Share Analysis, By Key Player, 2012
Figure 9 Global Conventional Injection Devices: Market Share Analysis, By Key Player, 2012
Figure 10 Global Self-Injection Devices: Market Share Analysis,By Key Player, 2012
Figure 11 Global Implantable Drug Delivery: Market Share Analysis,By Key Player, 2012
Figure 12 Opportunity Matrix: Global Drug Delivery Market (2012)
Figure 13 Oral Drug Delivery Market Share (2012)
Figure 14 Key Growth Strategies, 2010 - 2013
Figure 15 3m Company: Total Revenue And R&D Expenses,2009 - 2011 ($Million)
Figure 16 Alkermes: Total Revenue And R&D Expenditure,2009 - 2011 ($Million)
Figure 17 Aptalis Pharma, Inc.: Total Revenue And R&D Expenses,2009 - 2011 ($Million)
Figure 18 Baxter International: Total Revenue And R&D Expenses,2010 - 2012 ($Million)
Figure 19 Becton, Dickinson: Total Revenue And R&D Expenditure,2010 - 2012 ($Million)
Figure 20 Catalent Pharma Solutions: Total Revenue And R&D Expenses, 2009 - 2011 ($Million)
Figure 21 Teva Pharmaceutical Industries Limited: Total Revenue And R&D Expenses, 2010 - 2012 ($Million)
Figure 22 Endo Health Solutions, Inc.: Total Revenue And R&D Expenses, 2010 - 2012 ($Million)
Figure 23 Johnson & Johnson, Inc.: Total Revenue And R&D Expenses, 2010 - 2012 ($Million)
Figure 24 Nektar Therapeutics, Inc.: Total Revenue And R&D Expenses, 2009 - 2011 ($Million)
Figure 25 Psivida Corporation: Total Revenue, 2009 - 2011 ($Million)
Figure 26 Skyepharma Plc: Total Revenue And R&D Expenses,2009 - 2011 ($Million)
Figure 27 The Dow Chemical Company: Total Revenue And R&D Expenses, 2010 - 2012 ($Million)
Figure 28 Valeant Pharmaceuticals: Total Revenue And R&D Expenses, 2010 - 2012 ($Million)
Figure 29 Ypsomed: Total Revenue And R&D Expenses,2009 - 2011 ($Million)

★調査レポート[世界のドラッグデリバリー(薬物送達)技術市場] ( Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017 / BT 1539) 販売に関する免責事項
[世界のドラッグデリバリー(薬物送達)技術市場] ( Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017 / BT 1539) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆